PPA
CMRX

Parametric Portfolio Associates’s Chimerix, Inc. CMRX Stock Holding History

Parametric Portfolio Associates’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$64K Sell
13,873
-10,763
-44% -$60K ﹤0.01% 3610
2021
Q4 		$158K Buy
24,636
+1,315
+6% +$7.89K ﹤0.01% 3468
2021
Q3 		$144K Buy
23,321
+637
+3% +$4.38K ﹤0.01% 3488
2021
Q2 		$181K Buy
22,684
+4,805
+27% +$40K ﹤0.01% 3424
2021
Q1 		$172K Buy
+17,879
New +$164K ﹤0.01% 3905
2020
Q2 		– Sell
-12,545
Closed -$18K – 4018
2020
Q1 		$18K Sell
12,545
-107,435
-90% -$188K ﹤0.01% 3897
2019
Q4 		$244K Sell
119,980
-189,225
-61% -$349K ﹤0.01% 3664
2019
Q3 		$727K Sell
309,205
-333,394
-52% -$963K ﹤0.01% 3188
2019
Q2 		$2.78M Buy
642,599
+120,092
+23% +$369K ﹤0.01% 2434
2019
Q1 		$1.1M Buy
522,507
+120,702
+30% +$275K ﹤0.01% 2985
2018
Q4 		$1.03M Buy
401,805
+170,218
+74% +$570K ﹤0.01% 2963
2018
Q3 		$901K Sell
231,587
-21,645
-9% -$92.2K ﹤0.01% 3156
2018
Q2 		$1.21M Buy
253,232
+12,433
+5% +$59.4K ﹤0.01% 2952
2018
Q1 		$1.25M Buy
240,799
+18,325
+8% +$92.9K ﹤0.01% 2902
2017
Q4 		$1.03M Sell
222,474
-25,219
-10% -$120K ﹤0.01% 3004
2017
Q3 		$1.3M Buy
247,693
+11,343
+5% +$55.8K ﹤0.01% 2875
2017
Q2 		$1.29M Sell
236,350
-46,598
-16% -$245K ﹤0.01% 2832
2017
Q1 		$1.8M Buy
282,948
+28,003
+11% +$159K ﹤0.01% 2513
2016
Q4 		$1.17M Buy
254,945
+14,172
+6% +$66.9K ﹤0.01% 2735
2016
Q3 		$1.33M Buy
240,773
+142,515
+145% +$652K ﹤0.01% 2622
2016
Q2 		$386K Buy
98,258
+21,561
+28% +$107K ﹤0.01% 3330
2016
Q1 		$392K Buy
76,697
+59,206
+338% +$387K ﹤0.01% 3462
2015
Q4 		$157K Sell
17,491
-4,134
-19% -$149K ﹤0.01% 3789
2015
Q3 		$826K Buy
21,625
+15,190
+236% +$750K ﹤0.01% 2450
2015
Q2 		$297K Buy
6,435
+507
+9% +$20.3K ﹤0.01% 3580
2015
Q1 		$223K Buy
5,928
+295
+5% +$11.7K ﹤0.01% 3709
2014
Q4 		$227K Buy
+5,633
New +$191K ﹤0.01% 3716

Other funds holding CMRX

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parametric Portfolio Associates's CMRX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Chimerix, Inc. (CMRX) stake by 44% in Q1 2022, selling an estimated $60K and leaving 13,873 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #3610.

Parametric Portfolio Associates first reported a position in CMRX in Q4 2014 and has held it in 27 quarters since. The position peaked at $2.78M in Q2 2019. 126 funds tracked by Wall St. Rank hold CMRX as of Q1 2022.

  • Parametric Portfolio Associates held 13,873 shares of Chimerix, Inc. worth $64K as of Q1 2022.
  • Parametric Portfolio Associates sold 10,763 Chimerix, Inc. shares in Q1 2022, an estimated $60K.
  • Chimerix, Inc. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3610 holding.
  • Parametric Portfolio Associates first reported a position in Chimerix, Inc. in Q4 2014 and has held it in 27 quarters since.
  • Parametric Portfolio Associates's Chimerix, Inc. position peaked at $2.78M in Q2 2019.
  • 126 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.